Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 30;11(1):e0003. doi: 10.5041/RMMJ.10386

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © 2020 Ayan and Cayam-Rand

This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Biosynthesis, Degradation, and Receptor Binding of AEA and 2-AG.

AEA is synthesized from membrane phospholipids in the postsynaptic neuron by NAPE-PLD. It crosses the synapse “against the traffic” and activates CB₁R and TRPV1 on the presynaptic neuron. Following reuptake to the presynaptic neuron by the EMT, AEA activates nuclear receptors—PPARs—and is degraded by FAAH.

THC directly activates CB₁R; CBD inhibits FAAH and EMT (increasing AEA levels), the endogenous ligand of CB₁R. Like AEA, CBD activates PPARs and TRPV1.

2-AG, 2-arachidonoylglycerol (blue ellipses and related lines); AA, arachidonic acid (green ellipses); AEA, anandamide (purple ellipses and related lines); CB₁R, cannabinoid type 1 receptor; CBD, cannabidiol; DAGL, diacylglycerol lipase; EMT, endocannabinoid membrane transporter (green tubes); FAAH, fatty acid amide hydrolase; GPR55, G protein-coupled receptor 55; MAGL, monoacylglycerol lipase; NAPE-PLD, N-acylphosphatidylethanolamine-specific phospholipase D; PPARs, peroxisome proliferator-activated receptors; THC, Δ9-tetrahydrocannabinol; TRPV1, transient receptor potential channels of vanilloid type-1. Broken lines = inhibition; half ellipses ( ) = receptors; hexagons = enzymes; yellow mesh = cell membrane. Thicker lines and half ellipses are of greater importance than the thinner ones. Black lines, other pathways; red lines, phytocannabinoid pathways.

Inline graphic — Biosynthesis, Degradation, and Receptor Binding of AEA and 2-AG.

AEA is synthesized from membrane phospholipids in the postsynaptic neuron by NAPE-PLD. It crosses the synapse “against the traffic” and activates CB₁R and TRPV1 on the presynaptic neuron. Following reuptake to the presynaptic neuron by the EMT, AEA activates nuclear receptors—PPARs—and is degraded by FAAH.

THC directly activates CB₁R; CBD inhibits FAAH and EMT (increasing AEA levels), the endogenous ligand of CB₁R. Like AEA, CBD activates PPARs and TRPV1.

2-AG, 2-arachidonoylglycerol (blue ellipses and related lines); AA, arachidonic acid (green ellipses); AEA, anandamide (purple ellipses and related lines); CB₁R, cannabinoid type 1 receptor; CBD, cannabidiol; DAGL, diacylglycerol lipase; EMT, endocannabinoid membrane transporter (green tubes); FAAH, fatty acid amide hydrolase; GPR55, G protein-coupled receptor 55; MAGL, monoacylglycerol lipase; NAPE-PLD, N-acylphosphatidylethanolamine-specific phospholipase D; PPARs, peroxisome proliferator-activated receptors; THC, Δ9-tetrahydrocannabinol; TRPV1, transient receptor potential channels of vanilloid type-1. Broken lines = inhibition; half ellipses ( ) = receptors; hexagons = enzymes; yellow mesh = cell membrane. Thicker lines and half ellipses are of greater importance than the thinner ones. Black lines, other pathways; red lines, phytocannabinoid pathways.